Migraine-associated vertigo: Diagnosis and treatment

Seminars in Neurology

Volumn 30, Issue 2, 2010, Pages 167-174

  Cha, Yoon Hee ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Dizziness; Migraine; Vertigo; Vestibular

Indexed keywords

ACETAZOLAMIDE; ANTIMIGRAINE AGENT; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAHISTINE; CALCIUM CHANNEL BLOCKING AGENT; DIMENHYDRINATE; DIPHENHYDRAMINE; FLUNARIZINE; HOMATROPINE; HYDROXYZINE; LAMOTRIGINE; LOMERIZINE; MECLOZINE; METOCLOPRAMIDE; NEUROPEPTIDE; PLACEBO; PROCHLORPERAZINE; PROMETHAZINE; SCOPOLAMINE; TOPIRAMATE; TRICYCLIC AMINE DERIVATIVE; UNCLASSIFIED DRUG; ZOLMITRIPTAN;

CLINICAL FEATURE; DIAGNOSTIC TEST; DIET THERAPY; DISEASE ASSOCIATION; DIZZINESS; GENETIC RISK; HUMAN; LIFESTYLE MODIFICATION; MENIERE DISEASE; MIGRAINE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TREMOR; VASOSPASM; VERTIGO; VESTIBULAR DISORDER;

ADRENERGIC BETA-ANTAGONISTS; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BRAIN; CALCIUM CHANNEL BLOCKERS; HUMANS; MIGRAINE DISORDERS; NEUROPHARMACOLOGY; VERTIGO; VESTIBULE, LABYRINTH;

EID: 77950548514     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0030-1249225     Document Type: Review

References (87)

1. Lee H, Sohn S I., Jung D K. et al. Migraine and isolated recurrent vertigo of unknown cause. Neurol Res 2002 24 (7) 663-665
2. Cha Y H., Lee H, Santell L S., Baloh R W. Association of benign recurrent vertigo and migraine in 208 patients. Cephalalgia 2009 29 (5) 550-555
3. Aragones J M., Fortes-Rego J, Fuste J, Cardozo A. Migraine: an alternative in the diagnosis of unclassified vertigo. Headache 1993 33 (3) 125-128
4. Oh A K., Lee H, Jen J C., Corona S, Jacobson K M., Baloh R W. Familial benign recurrent vertigo. Am J Med Genet 2001 100 (4) 287-291
5. Slater R. Benign recurrent vertigo. J Neurol Neurosurg Psychiatry 1979 42 (4) 363-367
6. Lee H, Jen J C., Wang H et al. A genome-wide linkage scan of familial benign recurrent vertigo: linkage to 22q12 with evidence of heterogeneity. Hum Mol Genet 2006 15 (2) 251-258
7. Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurology 1999 246 883-892
8. Bikhazi P, Jackson C, Ruckenstein M J. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol 1997 18 (3) 350-354
9. Cutrer F M., Baloh R W. Migraine-associated dizziness. Headache 1992 32 (6) 300-304
10. Brantberg K, Trees N, Baloh R W. Migraine-associated vertigo. Acta Otolaryngol 2005 125 (3) 276-279
11. Savundra P A., Carroll J D., Davies R A., Luxon L M. Migraine-associated vertigo. Cephalalgia 1997 17 (4) 505-510, discussion 487
12. Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology 2001 56 (4) 436-441
13. Cass S P., Furman J M., Ankerstjerne K, Balaban C, Yetiser S, Aydogan B. Migraine-related vestibulopathy. Ann Otol Rhinol Laryngol 1997 106 (3) 182-189
14. Neuhauser H K., von Brevern M, Radtke A et al. Epidemiology of vestibular vertigo: a neurotologic survey of the general population. Neurology 2005 65 (6) 898-904
15. Baier B, Stieber N, Dieterich M. Vestibular-evoked myogenic potentials in vestibular migraine. J Neurol 2009 256 (9) 1447-1454
16. Celebisoy N, Gkay F, Sirin H, Biak N. Migrainous vertigo: clinical, oculographic and posturographic findings. Cephalalgia 2008 28 (1) 72-77
17. Teggi R, Colombo B, Bernasconi L, Bellini C, Comi G, Bussi M. Migrainous vertigo: results of caloric testing and stabilometric findings. Headache 2009 49 (3) 435-444
18. Baier B, Winkenwerder E, Dieterich M. Vestibular migraine: effects of prophylactic therapy with various drugs. A retrospective study. J Neurol 2009 256 (3) 436-442
19. Vitkovic J, Paine M, Rance G. Neuro-otological findings in patients with migraine- and nonmigraine-related dizziness. Audiol Neurootol 2008 13 (2) 113-122
20. Neuhauser H K. Epidemiology of vertigo. Curr Opin Neurol 2007 20 (1) 40-46
21. Neuhauser H K., Radtke A, von Brevern M et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology 2006 67 (6) 1028-1033
22. Kayan A, Hood J D. Neuro-otological manifestations of migraine. Brain 1984 107 (Pt 4) 1123-1142
23. Battista R A. Audiometric findings of patients with migraine-associated dizziness. Otol Neurotol 2004 25 (6) 987-992
24. Committee on Hearing and Equilibrium Guidelines for the Diagnosis and Evaluation of Therapy in Menire's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995 113 (3) 181-185
25. Basser L S. Benign paroxysmal vertigo of childhood (a variety of vestibular neuronitis). Brain 1964 87 141-152
26. Fenichel G M. Migraine as a cause of benign paroxysmal vertigo of childhood. J Pediatr 1967 71 (1) 114-115
27. Lanzi G, Balottin U, Fazzi E, Rosano F B. The periodic syndrome in pediatric migraine sufferers. Cephalalgia 1983 3 (Suppl 1) 91-93
28. Lanzi G, Balottin U, Fazzi E, Tagliasacchi M, Manfrin M, Mira E. Benign paroxysmal vertigo of childhood: a long-term follow-up. Cephalalgia 1994 14 (6) 458-460
29. Drigo P, Carli G, Laverda A M. Benign paroxysmal vertigo of childhood. Brain Dev 2001 23 (1) 38-41
30. Abu-Arafeh I, Russell G. Paroxysmal vertigo as a migraine equivalent in children: a population-based study. Cephalalgia 1995 15 (1) 22-25, discussion 4
31. Marcelli V, Piazza F, Pisani F, Marciano E. Neuro-otological features of benign paroxysmal vertigo and benign paroxysmal positioning vertigo in children: a follow-up study. Brain Dev 2006 28 (2) 80-84
32. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders, 2nd Ed. Cephalalgia 2004 24 (Suppl 1) 1-160
33. Wang C T., Lai M S., Young Y H. Relationship between basilar-type migraine and migrainous vertigo. Headache 2009 49 (3) 426-434
34. Eviatar L. Vestibular testing in basilar artery migraine. Ann Neurol 1981 9 (2) 126-130
35. Olsson J E. Neurotologic findings in basilar migraine. Laryngoscope 1991 101 (1 Pt 2, Suppl 52) 1-41
36. Perez-Garrigues H, Lopez-Escamez J A., Perez P et al. Time course of episodes of definitive vertigo in Meniere's disease. Arch Otolaryngol Head Neck Surg 2008 134 (11) 1149-1154
37. Rassekh C H., Harker L A. The prevalence of migraine in Menire's disease. Laryngoscope 1992 102 (2) 135-138
38. Parker W. Menire's disease. Etiologic considerations. Arch Otolaryngol Head Neck Surg 1995 121 (4) 377-382
39. Hinchcliffe R. Headache and Menire's disease. Acta Otolaryngol 1967 63 (4) 384-390
40. Radtke A, Lempert T, Gresty M A., Brookes G B., Bronstein A M., Neuhauser H. Migraine and Mnire's disease: is there a link? Neurology 2002 59 (11) 1700-1704
41. Cha Y H., Brodsky J, Ishiyama G, Sabatti C, Baloh R W. The relevance of migraine in patients with Meire's disease. Acta Otolaryngol 2007 127 (12) 1241-1245
42. Cha Y H., Kane M J., Baloh R W. Familial clustering of migraine, episodic vertigo, and Mnire's disease. Otol Neurotol 2008 29 (1) 93-96
43. Johnson G D. Medical management of migraine-related dizziness and vertigo. Laryngoscope 1998 108 (1 Pt 2) 1-28
44. Reploeg M D., Goebel J A. Migraine-associated dizziness: patient characteristics and management options. Otol Neurotol 2002 23 (3) 364-371
45. Bir L S., Ardi F N., Kara C O., Akalin O, Pinar H S., Celiker A. Migraine patients with or without vertigo: comparison of clinical and electronystagmographic findings. J Otolaryngol 2003 32 (4) 234-238
46. Kuritzky A, Toglia U J., Thomas D. Vestibular function in migraine. Headache 1981 21 (3) 110-112
47. Zhou G, Cox L C. Vestibular evoked myogenic potentials: history and overview. Am J Audiol 2004 13 (2) 135-143
48. Welgampola M S., Colebatch J G. Characteristics and clinical applications of vestibular-evoked myogenic potentials. Neurology 2005 64 (10) 1682-1688
49. Liao L-J, Young Y-H. Vestibular evoked myogenic potentials in basilar artery migraine. Laryngoscope 2004 114 (7) 1305-1309
50. Chen C-H, Young Y-H. Vestibular evoked myogenic potentials in brainstem stroke. Laryngoscope 2003 113 (6) 990-993
51. Allena M, Magis D, De Pasqua V, Schoenen J, Bisdorff A R. The vestibulo-collic reflex is abnormal in migraine. Cephalalgia 2007 27 (10) 1150-1155
52. Roceanu A, Allena M, De Pasqua V, Bisdorff A, Schoenen J. Abnormalities of the vestibulo-collic reflex are similar in migraineurs with and without vertigo. Cephalalgia 2008 28 (9) 988-990
53. von Brevern M, Zeise D, Neuhauser H, Clarke A H., Lempert T. Acute migrainous vertigo: clinical and oculographic findings. Brain 2005 128 (Pt 2) 365-374
54. Lee H, Jen J C., Cha Y H., Nelson S F., Baloh R W. Phenotypic and genetic analysis of a large family with migraine-associated vertigo. Headache 2008 48 (10) 1460-1467
55. Lee H, Sininger L, Jen J C., Cha Y H., Baloh R W., Nelson S F. Association of progesterone receptor with migraine-associated vertigo. Neurogenetics 2007 8 (3) 195-200
56. von Brevern M, Ta N, Shankar A et al. Migrainous vertigo: mutation analysis of the candidate genes CACNA1A, ATP1A2, SCN1A, and CACNB4. Headache 2006 46 (7) 1136-1141
57. Viirre E S., Baloh R W. Migraine as a cause of sudden hearing loss. Headache 1996 36 (1) 24-28
58. Lee H, Whitman G T., Lim J G. et al. Hearing symptoms in migrainous infarction. Arch Neurol 2003 60 (1) 113-116
59. Tippin J, Corbett J J., Kerber R E., Schroeder E, Thompson H S. Amaurosis fugax and ocular infarction in adolescents and young adults. Ann Neurol 1989 26 (1) 69-77
60. Winterkorn J M., Kupersmith M J., Wirtschafter J D., Forman S. Brief report: treatment of vasospastic amaurosis fugax with calcium-channel blockers. N Engl J Med 1993 329 (6) 396-398
61. Kruit M, van Buchem M, Launer L, Terwindt G, Ferrari M. Migraine is associated with an increased risk of deep white matter lesions, subclinical posterior circulation infarcts and brain iron accumulation: the population-based MRI CAMERA study. Cephalalgia 2009 Jun 8. (Epub ahead of print)
62. Ohno K, Takeda N, Yamano M, Matsunaga T, Tohyama M. Coexistence of acetylcholine and calcitonin gene-related peptide in the vestibular efferent neurons in the rat. Brain Res 1991 566 (1-2) 103-107
63. Sewell W F., Starr P A. Effects of calcitonin gene-related peptide and efferent nerve stimulation on afferent transmission in the lateral line organ. J Neurophysiol 1991 65 (5) 1158-1169
64. Ho T W., Mannix L K., Fan X et al, MK-0974 Protocol 004 study group. Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine. Neurology 2008 70 (16) 1304-1312
65. Zajonc T P., Roland P S. Vertigo and motion sickness. Part II: Pharmacologic treatment. Ear Nose Throat J 2006 85 (1) 25-35
66. Neuhauser H, Radtke A, von Brevern M, Lempert T. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology 2003 60 (5) 882-883
67. Marcus D A., Furman J M. Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. Med Sci Monit 2006 12 (1) PI1-PI7
68. Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope 2006 116 1782-1786
69. Carmona S, Settecase N. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann N Y Acad Sci 2005 1039 517-520
70. Bisdorff A R. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb 2004 (2) 103-108
71. Lampl C, Buzath A, Klinger D, Neumann K. Lamotrigine in the prophylactic treatment of migraine auraa pilot study. Cephalalgia 1999 19 (1) 58-63
72. D'Andrea G, Granella F, Cadaldini M, Manzoni G C. Effectiveness of lamotrigine in the prophylaxis of migraine with aura: an open pilot study. Cephalalgia 1999 19 (1) 64-66
73. Ophoff R A., Terwindt G M., Vergouwe M N. et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4. Cell 1996 87 (3) 543-552
74. Jen J, Kim G W., Baloh R W. Clinical spectrum of episodic ataxia type 2. Neurology 2004 62 (1) 17-22
75. Zasorin N L., Baloh R W., Myers L B. Acetazolamide-responsive episodic ataxia syndrome. Neurology 1983 33 (9) 1212-1214
76. Calandriello L, Veneziano L, Francia A et al. Acetazolamide-responsive episodic ataxia in an Italian family refines gene mapping on chromosome 19p13. Brain 1997 120 (Pt 5) 805-812
77. Baloh R W., Foster C A., Yue Q, Nelson S F. Familial migraine with vertigo and essential tremor. Neurology 1996 46 (2) 458-460
78. Rascol O, Hain T C., Brefel C, Benazet M, Clanet M, Montastruc J L. Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs 1995 50 (5) 777-791
79. Rascol O, Clanet M, Montastruc J L. Calcium antagonists and the vestibular system: a critical review of flunarizine as an antivertigo drug. Fundam Clin Pharmacol 1989 3 (Suppl) 79s-87s
80. Iwasaki S, Ushio M, Chihara Y, Ito K, Sugasawa K, Murofushi T. Migraine-associated vertigo: clinical characteristics of Japanese patients and effect of lomerizine, a calcium channel antagonist. Acta Otolaryngol Suppl 2007 (559) 45-49
81. Schmidt J T., Huizing E H. The clinical drug trial in Menire's disease with emphasis on the effect of betahistine SR. Acta Otolaryngol Suppl 1992 497 1-189
82. Brandt T, Zwergal A, Strupp M. Medical treatment of vestibular disorders. Expert Opin Pharmacother 2009 10 (10) 1537-1548
83. de Bock G H., Eelhart J, van Marwijk H W., Tromp T P., Springer M P. A postmarketing study of flunarizine in migraine and vertigo. Pharm World Sci 1997 19 (6) 269-274
84. Whitney S L., Wrisley D M., Brown K E., Furman J M. Physical therapy for migraine-related vestibulopathy and vestibular dysfunction with history of migraine. Laryngoscope 2000 110 (9) 1528-1534
85. Wrisley D M., Whitney S L., Furman J M. Vestibular rehabilitation outcomes in patients with a history of migraine. Otol Neurotol 2002 23 (4) 483-487
86. Best C, Eckhardt-Henn A, Tschan R, Dieterich M. Psychiatric morbidity and comorbidity in different vestibular vertigo syndromes. Results of a prospective longitudinal study over one year. J Neurol 2009 256 (1) 58-65
87. Eckhardt-Henn A, Best C, Bense S et al. Psychiatric comorbidity in different organic vertigo syndromes. J Neurol 2008 255 (3) 420-428